Although environmental factors play the major role in the development of multiple sclerosis (MS; OMIM: 126200), genetic factors are implicated as well. Firstly, variants in human leukocyte antigen (HLA) complex genes are known to confer susceptibility to MS.
Introduction
Although environmental factors play the major role in the development of multiple sclerosis (MS; OMIM: 126200), genetic factors are implicated as well. Firstly, variants in human leukocyte antigen (HLA) complex genes are known to confer susceptibility to MS.
The strongest evidence in this respect exists for the HLA-DRB1*15:01 haplotype. Secondly, over a hundred single-nucleotide polymorphisms not related to HLA system are also known to influence the risk and/or course of this disease [1] . A number of studies specifi cally investigated the potential associations between genetic variants and measures of central nervous system involvement in magnetic resonance (MR) imaging. We aimed to systematically review the literature on this topic and present the main data in a legible format. ." All types of documents were thus searched without a time limit. The 290 results were exported and further analyzed after excluding one item published before the year 1980, when magnetic resonance was fi rst used in a clinical setting; although the fi rst studies of genetic polymorphisms in MS were performed later, we did not fi lter our results further on the basis of the year published. All the entries were written in English. After screening titles and abstracts for information confi rming that the studies investigated genetic variants, 91 of them were selected for further assessment. Among these, 26 reported investigating a possible link between genetic variation and radiological fi ndings in the abstract; these were chosen for the fi nal analysis (there were no duplicates). One of the articles was not included since the full text could not be obtained and imaging-related results in the abstract were unclear [3] . Another article was identifi ed as relevant in references of the chosen studies [4] . We followed the approach proposed in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [5] .
Material and methods
On December
Results
Out of 26 studies, 20 found relationships between genetic variants and radiological fi ndings in MR imaging of the central nervous system ( Table 1) . The two genome-wide association studies (GWAS) provided a wealth of data [8, 19] . Of special interest are also the works by Sombekke et al., in which variants found in 44 MS-related genes were analyzed in the context of MR fi ndings [14] , and by Inkster et al., who focused on genes involved in epigenetic regulation [12] . The relationships between one or more HLA haplotypes and MR measures were searched for by seven non-GWAS studies. The remaining studies focused on particular genes of interest, of which most commonly researched were BDNF and CCR5. The methods of MR data acquisition and image method analysis varied between the studies, as did characteristics of patient groups.
None of the SNPs that were top-rated by the study of 44 genes by Sombekke et as well as CDH13 (rs692612) and PLCB1 (rs6118257) (lesion load). The relationship between BDNF rs6265 (Val66Met) and the radiologic course of MS was not consistently replicated across the studies. While this was also true for HLA-DRB1*15:01, the recent evidence is convincing [6] . Overall, few positive fi ndings of the reported studies were consistent.
Discussion
This brief systematic review gathered the data relating genetic variants to MR correlates of neurological lesions in MS. Any comparison of the included studies should consider the fact that MS diagnostic criteria constantly evolve [32] . MR imaging was featured in the clinical criteria in the year 2001, then reviewed in 2005 and 2010. For instance, the latest revision of McDonald criteria permit for an earlier MS diagnosis, but at the cost of the specifi city. The work to further improve the guidelines is ongoing [33] .
The association of MR measures in MS patients and CDH13, PLCB1, PTPRD, OPCML, and WWOX polymorphisms listed above warrants additional study. In conclusion, genetic variants were shown to correlate with MS-related brain atrophy and lesion load. 
